Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of herpes zoster (shingles) vaccine(recombinant, adjuvanted) deliveries will be required from 1 April 2021 to 31 March 2023, with an option to extend for up to an additional 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| GlaxoSmithKline UK Ltd | 04310159 | £66,131,483 | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| GlaxoSmithKline UK Ltd - Vaccines | - | £132,262,966 | - |
Government spending data: These suppliers have received £291,004,195 in 110 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2021-01-21 to 2026-03-12).